Qigong for Post Acute Sequelae of COVID-19 Infection
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to conduct a pilot feasibility study of a combination of external and internal qigong on health-related quality of life in individuals with prolonged symptoms following COVID-19 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2023
CompletedStudy Start
First participant enrolled
January 4, 2023
CompletedFirst Posted
Study publicly available on registry
January 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2024
CompletedJanuary 13, 2026
July 1, 2025
1.4 years
January 4, 2023
January 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in physical and mental health
Changes in PROMIS-29 summary scores from before to after intervention in all participants
8 weeks
Study Arms (2)
Immediate
EXPERIMENTALReceives 6 sessions of qigong first.
Waitlist Control
OTHERReceives 6 sessions of qigong after the immediate group
Interventions
6 sessions of combined external and internal qigong delivered in a group-based format once a week.
Eligibility Criteria
You may qualify if:
- English-speaking adults age 18 or greater
- History of a COVID-19 infection with lingering symptoms lasting longer than 12 weeks
- Willing and able to access the internet to complete questionnaires
- Willing and able to travel to the qigong sessions to participate in person in Sacramento, CA.
You may not qualify if:
- Lung scarring secondary to COVID-19 infection as evidenced by signs of parenchymal lung damage on imaging or FVC \< 80% (any patient with post COVID-related shortness of breath must have PFTs to be considered for enrollment).
- Dementia
- Any other condition that makes it difficult for the individual to complete questionnaires or attend the qigong sessions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California Davis Health
Sacramento, California, 95817, United States
Related Publications (1)
Joy M, Adams N, Yanuck M, Dossett ML. Experiences with Qi and changes in post-acute sequelae of COVID-19 (PASC) symptoms with qigong: a qualitative analysis of participants' experiences in a pilot clinical trial. BMC Complement Med Ther. 2025 Nov 28;25(1):434. doi: 10.1186/s12906-025-05161-w.
PMID: 41316170DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor in Residence
Study Record Dates
First Submitted
January 4, 2023
First Posted
January 9, 2023
Study Start
January 4, 2023
Primary Completion
May 15, 2024
Study Completion
May 15, 2024
Last Updated
January 13, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Must submit written request and complete data sharing agreement.